SS Innovations International Reports Record Q1 Revenue of $11.1 Million, Surgical Robotics Installed Base Grows to 194 Systems
SS Innovations International Inc. (NASDAQ: SSII) announced record first-quarter 2026 financial results, with revenue surging 116.8% year over year to $11.1 million, according to the company's earnings release. The growth was fueled by increasing adoption of its SSi Mantra surgical robotic system, which has now been installed in 194 units across 11 countries. The company also reported that cumulative robotic procedures reached nearly 9,750 by the end of the quarter, with an updated total of 11,719 procedures as of June 22, 2026.
The strong financial performance underscores the company's expanding footprint in the global surgical robotics market. Gross profit rose to $5.3 million from $1.1 million in the prior year, reflecting improved operational efficiency. The company attributed the revenue growth to higher system installations and increased procedure volumes, particularly in emerging markets where regulatory approvals have been secured.
During the quarter, SS Innovations received regulatory clearances in Sri Lanka, Kenya, Indonesia, and the Philippines, broadening its international market access. The company is also pursuing regulatory approvals in the United States and Europe, which could open significant new opportunities. In a notable achievement, SS Innovations completed the world's longest-distance robotic cardiac telesurgery, demonstrating the capabilities of its remote surgery platform and highlighting its potential to expand access to specialized surgical care.
The SSi Mantra system has been utilized for over 170 different types of procedures, including 612 cardiac surgeries, 175 telesurgeries, and 212 pediatric surgeries. Approximately 2,100 physicians have been trained on the system, indicating growing clinical acceptance. The company's focus on multi-specialty applications and telesurgery positions it as a key player in the evolving healthcare landscape, where remote and robotic-assisted surgeries are becoming increasingly important.
For more information, visit the company’s website at www.SSInnovations.com. The full earnings release and additional details are available on the InvestorWire website at https://www.InvestorWire.com.
This news story relied on content distributed by InvestorBrandNetwork (IBN). Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is SS Innovations International Reports Record Q1 Revenue of $11.1 Million, Surgical Robotics Installed Base Grows to 194 Systems.